GSK-3β inhibitor 22

Overview

GSK-3β inhibitor 22 (compound 20o) is a GSK-3β inhibitor with an IC 50 of 3.1 nM. GSK-3β inhibitor 22 has the potential of the study of Alzheimer's disease.

Application

Products | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Pancreatic Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Depression | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Obesity | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Digestive System Disease | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Stem Cell/Wnt | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > GSK-3

Product Information

• Catalog No.: HY-164907
• CAS No.: 1005199-84-7
• Molecular Formula: C18H12F3N3O2S2
• Molecular Weight: 423.43
• Purity: 99.38%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (5.90 mM); Clear solution
• Availability: In-stock

Source

Original product source